Published in J Virol on August 01, 2005
Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis. Viruses (2010) 1.13
Enhancement of LFA-1-mediated T cell adhesion by human T lymphotropic virus type 1 p12I1. J Immunol (2006) 1.06
Protein kinase C delta is required for survival of cells expressing activated p21RAS. J Biol Chem (2007) 1.04
Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo. J Virol (2006) 1.02
HTLV-1 and apoptosis: role in cellular transformation and recent advances in therapeutic approaches. Apoptosis (2008) 0.99
Suppression of HTLV-1 replication by Tax-mediated rerouting of the p13 viral protein to nuclear speckles. Blood (2011) 0.94
Comparison of the Genetic Organization, Expression Strategies and Oncogenic Potential of HTLV-1 and HTLV-2. Leuk Res Treatment (2011) 0.94
Molecular determinants of human T-lymphotropic virus type 1 transmission and spread. Viruses (2011) 0.92
HTLV-1 and HTLV-2: highly similar viruses with distinct oncogenic properties. Front Microbiol (2014) 0.89
Orf-I and orf-II-encoded proteins in HTLV-1 infection and persistence. Viruses (2011) 0.88
Mechanisms of pathogenesis induced by bovine leukemia virus as a model for human T-cell leukemia virus. Front Microbiol (2013) 0.88
Overview on HTLV-1 p12, p8, p30, p13: accomplices in persistent infection and viral pathogenesis. Front Microbiol (2012) 0.88
HTLV-1 p13, a small protein with a busy agenda. Mol Aspects Med (2010) 0.87
Converging strategies in expression of human complex retroviruses. Viruses (2011) 0.86
HTLV-1 Infection and Adult T-Cell Leukemia/Lymphoma-A Tale of Two Proteins: Tax and HBZ. Viruses (2016) 0.82
Molecular aspects of HTLV-I infection and adult T-cell leukaemia/lymphoma. J Clin Pathol (2007) 0.80
Ras signaling contributes to survival of human T-cell leukemia/lymphoma virus type 1 (HTLV-1) Tax-positive T-cells. Apoptosis (2012) 0.78
Cotranscriptional Chromatin Remodeling by Small RNA Species: An HTLV-1 Perspective. Leuk Res Treatment (2012) 0.76
The dark side of Ras: regulation of apoptosis. Oncogene (2003) 2.60
Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: novel mRNAs and proteins produced by HTLV type I. J Virol (1992) 2.52
FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity (1995) 2.19
Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones. Virology (1994) 2.14
HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication. Nat Med (2004) 1.97
The p12I, p13II, and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments. J Virol (1993) 1.77
X-I and X-II open reading frames of HTLV-I are not required for virus replication or for immortalization of primary T-cells in vitro. Virology (1997) 1.61
Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo. J Virol (2000) 1.61
Evidence for the chronic in vivo production of human T cell leukemia virus type I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptides. J Exp Med (2000) 1.57
Human T-cell leukemia virus type 1 pX-I and pX-II open reading frames are dispensable for the immortalization of primary lymphocytes. J Virol (1998) 1.52
Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo. Leukemia (2003) 1.39
Seizing of T cells by human T-cell leukemia/lymphoma virus type 1. Adv Cancer Res (2003) 1.38
Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversion. J Virol (2004) 1.37
Repression of human T-cell leukemia virus type 1 and type 2 replication by a viral mRNA-encoded posttranscriptional regulator. J Virol (2004) 1.34
Mitochondrial targeting of the p13II protein coded by the x-II ORF of human T-cell leukemia/lymphotropic virus type I (HTLV-I). Oncogene (1999) 1.34
The human T-cell leukemia/lymphotropic virus type 1 p12I proteins bind the interleukin-2 receptor beta and gammac chains and affects their expression on the cell surface. J Virol (1996) 1.33
Ras regulation of NF-kappa B and apoptosis. Methods Enzymol (2001) 1.30
Expression and characterization of proteins produced by mRNAs spliced into the X region of the human T-cell leukemia/lymphotropic virus type II. Virology (1995) 1.20
Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesis. Microbiol Mol Biol Rev (2002) 1.20
Mitochondrial alterations induced by the p13II protein of human T-cell leukemia virus type 1. Critical role of arginine residues. J Biol Chem (2002) 1.17
Ceramide regulates cellular homeostasis via diverse stress signaling pathways. Leukemia (2001) 1.16
Ras biochemistry and farnesyl transferase inhibitors: a literature survey. Anticancer Drugs (2001) 1.16
In vitro and in vivo oncogenic potential of bovine leukemia virus G4 protein. J Virol (1998) 1.14
Ceramide signaling in apoptosis. Br Med Bull (1997) 1.10
Human T-cell lymphotropic virus type 1 p12I enhances interleukin-2 production during T-cell activation. J Virol (2003) 1.07
Bcl-2, via its BH4 domain, blocks apoptotic signaling mediated by mitochondrial Ras. J Biol Chem (2002) 1.05
Farnesyl transferase inhibitors: a novel targeted tnerapy for cancer. Lancet Oncol (2001) 1.05
Role of accessory proteins of HTLV-1 in viral replication, T cell activation, and cellular gene expression. Front Biosci (2004) 1.05
Oncoviral bovine leukemia virus G4 and human T-cell leukemia virus type 1 p13(II) accessory proteins interact with farnesyl pyrophosphate synthetase. J Virol (2002) 1.04
Suppression of tumor growth and cell proliferation by p13II, a mitochondrial protein of human T cell leukemia virus type 1. Proc Natl Acad Sci U S A (2004) 0.99
The human T-cell lymphotropic virus type 1 Tof protein contains a bipartite nuclear localization signal that is able to functionally replace the amino-terminal domain of Rex. J Virol (1997) 0.98
Subcellular localization of the bovine leukemia virus R3 and G4 accessory proteins. J Virol (2002) 0.97
The p13II protein of HTLV type 1: comparison with mitochondrial proteins coded by other human viruses. AIDS Res Hum Retroviruses (2000) 0.96
Genetic variability and molecular epidemiology of human and simian T cell leukemia/lymphoma virus type I. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.92
Adult T-cell leukemia/lymphoma: a cytopathologic, immunocytochemical, and flow cytometric study. Cancer (2002) 0.91
HTLV type 1 Tax transduction in microglial cells and astrocytes by lentiviral vectors. AIDS Res Hum Retroviruses (2000) 0.89
Immortalization of T lymphocytes by human T-cell leukemia virus type 1 is independent of the tax-CBP/p300 interaction. J Virol (2000) 0.87
Expression and functional properties of proteins encoded in the x-II ORF of HTLV-I. Virus Res (2001) 0.78
Cytoreductive effects of farnesyl transferase inhibitors on multiple myeloma tumor cells. Mol Cancer Ther (2003) 0.77
Human T-cell leukemia/lymphoma virus type 1 nonstructural genes and their functions. Oncogene (2005) 1.38
Society of Toxicologic Pathology position paper: organ weight recommendations for toxicology studies. Toxicol Pathol (2007) 1.24
Kinetics and intracellular compartmentalization of HTLV-1 gene expression: nuclear retention of HBZ mRNAs. Blood (2011) 1.18
Mitochondrial alterations induced by the p13II protein of human T-cell leukemia virus type 1. Critical role of arginine residues. J Biol Chem (2002) 1.17
Human T-cell lymphotropic virus type 1 p12I enhances interleukin-2 production during T-cell activation. J Virol (2003) 1.07
Role of accessory proteins of HTLV-1 in viral replication, T cell activation, and cellular gene expression. Front Biosci (2004) 1.05
Oncoviral bovine leukemia virus G4 and human T-cell leukemia virus type 1 p13(II) accessory proteins interact with farnesyl pyrophosphate synthetase. J Virol (2002) 1.04
Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation. Oncotarget (2014) 1.04
Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo. J Virol (2006) 1.02
Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma. PLoS One (2009) 0.99
Suppression of tumor growth and cell proliferation by p13II, a mitochondrial protein of human T cell leukemia virus type 1. Proc Natl Acad Sci U S A (2004) 0.99
The human T-lymphotropic virus type 1 tax protein inhibits nonsense-mediated mRNA decay by interacting with INT6/EIF3E and UPF1. J Virol (2012) 0.99
Modulation of mitochondrial K(+) permeability and reactive oxygen species production by the p13 protein of human T-cell leukemia virus type 1. Biochim Biophys Acta (2009) 0.97
Subcellular localization of the bovine leukemia virus R3 and G4 accessory proteins. J Virol (2002) 0.97
Hypoxia inducible factor-1alpha inactivation unveils a link between tumor cell metabolism and hypoxia-induced cell death. Am J Pathol (2008) 0.95
Imaging spontaneous tumorigenesis: inflammation precedes development of peripheral NK tumors. Blood (2008) 0.95
Comparison of the Genetic Organization, Expression Strategies and Oncogenic Potential of HTLV-1 and HTLV-2. Leuk Res Treatment (2011) 0.94
T-cell activation promotes tumorigenesis in inflammation-associated cancer. Retrovirology (2009) 0.93
Control of cell death pathways by HTLV-1 proteins. Front Biosci (Landmark Ed) (2009) 0.93
Highlights on distinctive structural and functional properties of HTLV Tax proteins. Front Microbiol (2013) 0.93
Effect of treatment of Strongyloides infection on HTLV-1 expression in a patient with adult T-cell leukemia. Am J Hematol (2007) 0.91
Redox regulation of T-cell turnover by the p13 protein of human T-cell leukemia virus type 1: distinct effects in primary versus transformed cells. Blood (2010) 0.91
Mitochondria as functional targets of proteins coded by human tumor viruses. Adv Cancer Res (2005) 0.90
Fine tuning of the temporal expression of HTLV-1 and HTLV-2. Front Microbiol (2013) 0.89
Engraftment and tumorigenesis of HTLV-1 transformed T cell lines in SCID/bg and NOD/SCID mice. Leuk Res (2002) 0.89
Measles virotherapy in a mouse model of adult T-cell leukaemia/lymphoma. J Gen Virol (2011) 0.88
In situ analysis of human menin in normal and neoplastic pancreatic tissues: evidence for differential expression in exocrine and endocrine cells. J Clin Endocrinol Metab (2003) 0.87
HTLV-1 p13, a small protein with a busy agenda. Mol Aspects Med (2010) 0.87
Conference highlights of the 15th International Conference on Human Retrovirology: HTLV and related retroviruses, 4-8 June 2011, Leuven, Gembloux, Belgium. Retrovirology (2011) 0.87
Converging strategies in expression of human complex retroviruses. Viruses (2011) 0.86
International Retrovirology Association brings together scientists and clinicians to bridge discoveries about human T-lymphotropic viruses from the laboratory to clinical trials. Retrovirology (2005) 0.85
Role of microRNAs in HTLV-1 infection and transformation. Mol Aspects Med (2010) 0.85
Relevance of CREB phosphorylation in the anti-apoptotic function of human T-lymphotropic virus type 1 tax protein in serum-deprived murine fibroblasts. Exp Cell Res (2004) 0.83
Effects of human T-cell leukemia virus type 1 (HTLV-1) p13 on mitochondrial K+ permeability: A new member of the viroporin family? FEBS Lett (2010) 0.83
Amiodarone alters late endosomes and inhibits SARS coronavirus infection at a post-endosomal level. Am J Respir Cell Mol Biol (2008) 0.83
Small noncoding RNAs in cells transformed by human T-cell leukemia virus type 1: a role for a tRNA fragment as a primer for reverse transcriptase. J Virol (2014) 0.83
What we are learning on HTLV-1 pathogenesis from animal models. Front Microbiol (2012) 0.81
Temporal regulation of HTLV-2 expression in infected cell lines and patients: evidence for distinct expression kinetics with nuclear accumulation of APH-2 mRNA. Retrovirology (2012) 0.81
Human T lymphotropic virus type 1 accessory protein p12I modulates calcium-mediated cellular gene expression and enhances p300 expression in T lymphocytes. AIDS Res Hum Retroviruses (2005) 0.81
Decreased expression and promoter methylation of the menin tumor suppressor in pancreatic ductal adenocarcinoma. Genes Chromosomes Cancer (2009) 0.81
Heterozygous disruption of renal outer medullary potassium channel in rats is associated with reduced blood pressure. Hypertension (2013) 0.81
Quantitative analysis of human T-lymphotropic virus type 1 (HTLV-1) gene expression using nucleo-cytoplasmic fractionation and splice junction-specific real-time RT-PCR (qRT-PCR). Methods Mol Biol (2014) 0.81
The microRNA regulatory network in normal- and HTLV-1-transformed T cells. Adv Cancer Res (2012) 0.80
The p13 protein of human T cell leukemia virus type 1 (HTLV-1) modulates mitochondrial membrane potential and calcium uptake. Biochim Biophys Acta (2010) 0.80
Retrovirus HTLV-1 gene circuit: a potential oscillator for eukaryotes. Pac Symp Biocomput (2010) 0.79
Sensitivity analysis of retrovirus HTLV-1 transactivation. J Comput Biol (2011) 0.79
Calcium-dependent enhancement of transcription of p300 by human T-lymphotropic type 1 p12I. Virology (2006) 0.79
Lack of effects on male fertility from a quadrivalent HPV vaccine in Sprague-Dawley rats. Birth Defects Res B Dev Reprod Toxicol (2010) 0.78
Synergistic antitumor activity of recombinant human Apo2L/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in combination with carboplatin and pemetrexed in malignant pleural mesothelioma. J Thorac Oncol (2014) 0.76